# The Jewel IDE Study

Study · id `cardio:ct-nct05201495` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05201495](<https://clinicaltrials.gov/study/NCT05201495>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05201495

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 322 participants.

## Technical summary

Registry record NCT05201495. Allocation not applicable; no masking; primary purpose treatment. Start 2022-01-12 (actual); primary completion 2023-11-10 (actual). Results posted on 2024-10-15.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 322 participants (enrolled count; ClinicalTrials.gov record NCT05201495, source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)
- Started: 2022-01-12 (actual) (ClinicalTrials.gov record NCT05201495, source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)
- Primary completion: 2023-11-10 (actual) (ClinicalTrials.gov record NCT05201495, source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)
- Completion: 2023-11-10 (actual) (ClinicalTrials.gov record NCT05201495, source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)
- Results first posted: 2024-10-15 (ClinicalTrials.gov record NCT05201495, source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05201495, source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05201495-2026-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Jewel IDE Study
- Condition: Sudden Cardiac Arrest
- Intervention (Device): Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
- Lead sponsor: Element Science, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)

## Provenance

Content hash: 98e75505160bca6791bbfa48d726f6ce347e0b3752d03b2924b93e8195413cd9
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
